KRAS and colonic neoplasm: Since colon cancer cell lines used in this study harbored either different KRAS or BRAF mutation (Table 1), our results suggest that B4GALNT3 knockdown suppressed cell malignant phenotype and cancer cell stemness irrelevantly to the status of KRAS and BRAF.